Wells Fargo keeps Nucor at "overweight" and raises price target from $305 to $308
Wells Fargo kept its rating on Nucor at "overweight" and raised its price target from $305 to $308, an increase of 1.0%. The new target implies 22.2% upside from the November 17 close of $252.08. The five most recent analyst notes on Nucor over the past 30 days set price targets between $301 and $345.
In 25 seconds
- Wells Fargo reiterates its "overweight" rating on Nucor.
- The price target rises from $305 to $308, 1.0% higher.
- The new target implies 22.2% upside from the November 17 close of $252.08.
IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.